|
|
|
|||
| Home Help Feedback Subscriptions Archive Search | ||||
The fully linked HTML version of this article has now been published.
We have used monoclonal antibodies against cell-surface developmental epitopes in combination with micromagnetic beads to isolate phenotypically defined subpopulations of cholangiocyte marker-positive fetal liver epithelial cells (CMP-FLEC). Differentiation potential was evaluated by injecting cell isolates from dipeptidyl peptidase IV (DPPIV) positive (DPPIV+) Fischer donor rats into the spleen of partially hepatectomized, DPPIV negative (DPPIV-) Fischer host rats exposed to retrorsine. At various time points, liver tissue was harvested and cells in DPPIV+ colonies were phenotyped by immunofluorescence and histochemical protocols. Functional differentiation and liver replacement were determined by comparing donor and host hepatocyte protein expression patterns and DPPIV enzyme activity in extracts from livers of host rats receiving CMP-FLEC. Our results showed that bipotentiality was retained during differentiation and maturation of CMP-FLEC, indicating that the acquisition of ductal morphology and phenotype were not indicative of lineage commitment. CMP-FLEC transplanted into the adult rat liver lost ductal and gained hepatocyte markers, and acquired protein expression patterns in 2D gels with a close similarity (>75% spot match) to host hepatocytes but differing significantly from the transplanted CMP-FLEC cell isolate (<25% spot match). The average size of donor hepatocyte colonies increased with time so that by 1 year, up to 70% of the host rat liver was replaced by CMP-FLEC derived DPPIV+ hepatocytes. Depletion of CMP-FLEC from fetal liver isolates resulted in a marked decrease in adult liver colonization, suggesting that a high percentage of the hepatocyte colonies in animals receiving total fetal liver isolates are derived from CMP-FLEC.
This article has been cited by other articles:
Development ePress online publication date 4 Oct 2006
doi: 10.1242/dev.02589
This Article ![]()
![]()
Full Text (PDF)
![]()
All Versions of this Article:
dev.02589v1
133/21/4269
most recent![]()
Alert me when this article is cited
![]()
Alert me if a correction is posted
![]()
Services ![]()
![]()
Email this article to a friend
![]()
Similar articles in this journal
![]()
Similar articles in PubMed
![]()
Alert me to new issues of the journal
![]()
Download to citation manager
![]()
![]()
Citing Articles ![]()
![]()
Citing Articles via HighWire
![]()
Citing Articles via Google Scholar
![]()
Google Scholar ![]()
![]()
Articles by Simper-Ronan, R. ![]()
Articles by Hixson, D. C. ![]()
Search for Related Content
![]()
PubMed ![]()
![]()
PubMed Citation
![]()
Articles by Simper-Ronan, R.
![]()
Articles by Hixson, D. C.
![]()
Social Bookmarking ![]()
![]()
What's this?
Research article
Cholangiocyte marker-positive and -negative fetal liver cells differ significantly in their ability to regenerate the livers of adult rats exposed to retrorsine
* Author for correspondence (e-mail: dhixson{at}lifespan.org)
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati
Twitter What's this?
![]()
![]()

![]()
![]()
![]()
N. Brezillon, D. Kremsdorf, and M. C. Weiss
Cell therapy for the diseased liver: from stem cell biology to novel models for hepatotropic human pathogens
Dis. Model. Mech.,
September 1, 2008;
1(2-3):
113 - 130.
[Abstract]
[Full Text]
[PDF]
![]()
© The Company of Biologists Ltd 2006